Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Insmed Inc (NASDAQ:INSM)

12.13
Delayed Data
As of 3:59pm ET
 +0.08 / +0.66%
Today’s Change
10.21
Today|||52-Week Range
19.35
-8.31%
Year-to-Date

Today’s Trading

Previous close12.05
Today’s open11.89
Day’s range11.89 - 12.38
Volume531,636
Average volume (3 months)424,678
Market cap$751.7M
Dividend yield--
Data as of 3:59pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-41.09%
Earnings growth (this year)+5.29%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.84

Competitors

 Today’s
change
Today’s
% change
ENTAEnanta Pharmaceutica...-1.55-3.92%
AKAOAchaogen Inc+0.33+1.84%
TGTXTG Therapeutics Inc-0.15-1.36%
ACRSAclaris Therapeutics...-0.30-1.19%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.71
Annual revenue (last year)$0.00
Annual profit (last year)-$176.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Will Lewis
Chief Financial Officer
Paolo Tombesi
Corporate headquarters
Bridgewater, New Jersey

Forecasts